Bought the seat, waiting for the ride: management describes a position already secured inside someone else's decision, w
The model's full reasoning — Q3 2023 call → NOWe need to determine if the transcript conveys that the company's near-term growth no longer depends on persuading anyone, because decisions have already been made by others, and the company is preparing to deliver, and is small relative to committed business. Let's analyze the transcript. Key points: - FUROSCIX launched, revenue growing. Q3 net revenue $3.8M, up 138% sequentially. - They added 12 sales territories, now 66. - Payer agreements: reached agreement with one of largest closed IDNs, providing unrestricted access without prior authorization to over 8 million lives at fixed copay. Also added on formulary as preferred brand with government retiree payer, increasing lives by 1.1 million. These expand access. - They mention "moves us towards our previously stated goal of having 75% or more heart failure patients nationally with fixed co-pays of $100 or less." - They anticipate positive impact on co-pays as early as Q4. - They are progressing with many other health plans, hope to have more announcements. - They have national Medicaid coverage effective July 1st, added specialty pharmacy. - Life cycle management: FDA feedback on Class 4 indication, filed in early October. Auto-injector development, PK study 2024, sNDA by end 2024. CKD indication, no additional clinical studies needed, plan to advance. - Commercial update: 1,119 unique prescribers, 1,579 total prescriptions in Q3, 877 filled, 442 pending. Fill rate 55% up from 52%. Average doses per prescription 5.6. In-services 1,806. - They added 12 territories at end of Q3, new reps trained and conducting face-to-face selling. - Marketing campaign ongoing. Now, the question: Does management convey that near-term growth no longer depends on persuading anyone, because decisions that govern it have already been made by others, and resulting activity has only just begun to reach the company? We need to see if the forward story rests on committed business from others, not on winning new customers. The payer agreements are examples: they have already secured access for 8 million lives, and another 1.1 million. That is a decision made by others (the IDN and the payer) to include FUROSCIX on formulary without prior authorization. That is a commitment.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
GOGO · Q1 2016 → YESThe question is whether management conveys that the company's near-term growth no longer depends on persuading anyone, because decisions have already been made by others, and activity has just begun t...YES The transcript shows management describing 2Ku awards exceeding 1000 aircraft as already decided by airlines (IAG, Air Canada, Delta, Shareco), with activity now centered on installation, STCs, and supply chain mobilization rather than further persuasion.
GIII · Q4 2024 → YESThe question is whether management conveys that the company's near-term growth no longer depends on persuading anyone, because decisions have already been made by others, and activity has just begun t...
FLL · Q3 2022 → YESThe question is about whether management conveys that the company's near-term growth no longer depends on persuading anyone, because decisions have already been made by others, and activity has just b...